Identification of a novel biomarker for sarcopenia diagnosis using serum metabolomic analysis: a pilot study.

This study is the first to identify hypoxanthine as a potential biomarker for sarcopenia in humans and provides new insights into the pathophysiology of sarcopenia. Furthermore, the identified metabolites may be useful for the early detection of sarcopenia.